ReznikY, CohenO, AronsonR, CongetI, RunzisS, CastanedaJ, LeeSW; OpT2mise Study Group. Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial. Lancet, 2014; 384: 1265–72.
2.
FrancS, DaoudiA, PochatA, PetitM-H, RandazzoC, PetitC, DuclosM, PenfornisA, PussardE, NotD, HeymanE, KoukouiF, SimonC, CharpentierG. Insulin-based strategies to prevent hypoglycaemia during and after exercise in adult patients with type 1 diabetes on pump therapy: the DIABRASPORT randomized study. Diabet Obes Metab, 2015; 17: 1150–57.
3.
LodefalkM, ÅmanJ, BangP. Effects of fat supplementation on glycaemic response and gastric emptying in adolescents with Type 1 diabetes. Diabet Med, 2008; 25: 1030–35.
4.
ThomsenC, StormH, HolstJJ, HermansenK. Differential effects of saturated and monounsaturated fats on postprandial lipemia and glucagon-like peptide 1 responses in patients with type 2 diabetes. Am J Clin Nutr, 2003; 77: 605–11.
5.
NixonR, FolwellR, PickupJC. Variations in the quality and sustainability of long-term glycaemic control with continuous subcutaneous insulin infusion. Diabet Med, 2014; 31: 1174–77.
6.
PickupJC, SuttonAJ. Severe hypoglycaemia and glycaemic control in type 1 diabetes: meta-analysis of multiple daily insulin injections versus continuous subcutaneous insulin infusion. Diabetic Med, 2008; 25: 765–74.
7.
CollierA, GhoshS, HairM, WaughN. Impact of socioeconomic status and gender on glycaemic control, cardiovascular risk factors and diabetes complications in type 1 and 2 diabetes: a population based analysis from a Scottish region. Diabetes Metab, 2015; 41: 145–51.
8.
LinMH, ConnorCG, RuedyKJ, BeckRW, KollmanC, BuckinghamB, RedondoMJ, SchatzD, HaroH, LeeJM, TamborlaneWV, WoodJR; Pediatric Diabetes Consortium. Race, socioeconomic status, and treatment center are associated with insulin pump therapy in youth in the first year following diagnosis of type 1 diabetes. Diabet Technol Therapeut, 2013; 15: 929–34.
